<DOC>
	<DOCNO>NCT00367302</DOCNO>
	<brief_summary>The purpose study determine feasibility provide buprenorphine maintenance opioid-dependent offender jail set transition patient buprenorphine maintenance community release .</brief_summary>
	<brief_title>Buprenorphine Maintenance Opioid-Addicted Persons Jail Post-Release</brief_title>
	<detailed_description>Background : Heroin opioid abuse continue significant problem among criminal justice population . In 2002 , criminal justice system source referral 36 % substance abuse treatment admission , large source referral . Heroin use among offender serious health social consequence . Injection , still primary route administration among heroin user , strongly associate transmission HIV , hepatitis C blood-borne disease . During 1997 , 20 % 26 % people live HIV United States , 29 % 43 % infected hepatitis C , pass correctional facility . The relationship heroin use criminal activity extensively document . Although methadone maintenance primary treatment chronic opioid dependence since 1970 's , correctional system U.S. , exception ( primarily Rikers Island New York City ) , provide institutional access methadone maintenance . Regrettably , negative attitude methadone prevalent among criminal justice professional , public , treatment provider opioid-dependent offender ; little prospect change soon . Buprenorphine maintenance recently approve therapy may acceptable methadone criminal justice system opioid-dependent offender . With one minor exception , buprenorphine never systematically administer opioid replacement therapy correctional setting U.S . Aims Objectives : 1 . To determine feasibility provide buprenorphine maintenance opioid-dependent offender jail set transition patient buprenorphine maintenance community release . 2 . To conduct randomized clinical trial buprenorphine maintenance ( N=50 ) vs. methadone maintenance ( N=50 ) initiate jail set continue community . 3 . To determine reason offender fail report community buprenorphine methadone treatment release drop community treatment . Study Design : Consenting eligible inmate Rikers Island New York City randomly assign buprenorphine methadone maintenance jail refer correspond community treatment upon release . Subjects followed-up 3 month release jail . Target Population : Opioid-dependent jail inmate sentence 10- 90 day .</detailed_description>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>opioid dependent patient meet eligibility requirement KEEP program , patient serve sentence remain confined least 10 day less 90 day EMTC facility ( male ) Rikers , willingness accept buprenorphine treatment , expect reside New York City release 1865 year age receive methadone treatment community sentence remand Rikers take nonprescribed 'street methadone ' within last 3 day currently receive 20mg/day methadone current psychotic symptom ( e.g. , schizophrenia , schizoaffective disorder ) require referral mental health intervention , current treatment antipsychotic medication ) HIV infection T lymphocytes less 200 per mm blood and/or presence serious opportunistic infection require treatment , receive HIV medication atazanavir . unable complete English language interview</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>addiction</keyword>
	<keyword>jail</keyword>
	<keyword>opiate</keyword>
	<keyword>buprenorphine</keyword>
	<keyword>clinical trial</keyword>
</DOC>